KENYA – Kenya and Oximio have collaborated to establish a new clinical trial logistics hub in Nairobi which will act as a gateway for medical logistics across Africa as well as change the landscape of clinical trials in the region.
Oximio is a clinical trial services provider that offers an end-to-end cold-chain control system in all its sites which contributes to research aimed at finding effective treatment for individuals globally.
The company has numerous competencies including supply planning and consulting, patient centricity, advanced therapy solutions, import & export regulations, warehousing, distribution services among others.
It provides world-class supply chain solutions to increase efficiency, lower the research cost per patient and ultimately attract more sponsors hence offering a wider spectrum of clinical research into all regions.
Under the deal, Oximio will provide clinical trial material, comparator medicines along with ancillary supplies to clinical sites across East, Central and West Africa through its new site in Kenya.
Oximio-Kenya partnership also creates end-to-end supply chain solutions for multinational clinical trials, attracting more sponsors and new technologies to the region to reach larger patient populations.
Oximio has a depot in Kenya located near Limuru which is just twenty-five minutes away from the Nairobi CBD and two minutes away from the road linking Nairobi with the country’s west.
The transit depot which has been fully operational and licensed from November 2021 reaches sites across the country borders at a faster rate and at a reduced cost compared with established supply chain models.
It offers storage distribution, manages end-to-end processes, comparator sourcing and courier services together with country-specific labeling and kit assembly services.
Sponsors can now optimize logistics costs by delegating authority to Oximio Kenya to utilize their blanket clinical trial approval from the Kenya Pharmacy and Poisons Board.
Consequently, the facility is licensed to store investigational medicine, medical devices, commercial medicines, ancillaries and other Pharmacy and Poisons Board-approved drugs.
Moreover, Kenya Revenue Authority has approved the facility as a transit customs warehouse which permits the direct release of imported consignments to the depot, where customs clearance allows continuous temperature control management.
The newly commissioned warehouse is designed to meet international standards to house Oximio’s leading cold-chain operations while maintaining good practice quality guidelines and regulations.
“Oximio is the only company providing clinical trial logistics support as a one-stop-shop for the sub-Saharan Africa continent even though the clinical trial industry is one of the most heavily regulated,” said Oximio Group CEO Krisztina Varga.
Krisztina Varga added that the clinical trial services provider carries out its duties through its local depot in Pretoria, South Africa, a partner depot in Egypt and now through the newly launched transit customs depot in Kenya.
“Our intention is to team up with sponsors and form strategic partnerships to create opportunities to enable more clinical trials in the Africa,” revealed Krisztina.
She further highlighted that significant partnerships for a better future is a key differentiator that elevates the patient focus in sub-Saharan Africa to convert the ever-changing face of investigational medical products into new medicines.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
